...single cells, or clusters, with rapid, smooth, pre... be targeted, then click-click on the keypad...the...ally transferred to the individual wells of a micr...sion system allows transfer of 1-5 cells at a time...
...A expression profiling and built on the flexible a... platform. These microarrays are available as part...g Service. Probe Content The Maize microRNA Mic...que mature sequences). The comprehensive probe con...
...ance of the LTQ, incorporating more techniques to ...entifics innovations in ion trap technology. Ther...er that offers multiple dissociation techniques, P...ciation (PQD) is a patented technique that elimina...
Varian CP-4900 Micro-GC from Varian, Inc.
Biology Products:(Date:12/2/2009)...a cap is good for you, at least if you are a mamma...ineering in Oncology Center have shown that in hea...holds the cell,s nucleus, its genetic storehouse, ...uence on cell and nuclear shape, the researchers s...ment of diseases such as cancer, muscular dystroph...
(Date:12/2/2009)...if., Dec. 2 DigitalPersona, Inc., ...n solutions, today announced an agreement with IBM...tric fingerprint technology on IBM SurePOS 500 ret...HD offering allows point-of-sale applications to m...ific transactions can be linked to the individuals...
(Date:12/2/2009)...09 Commonly prescribed beta 2 adrenergic agonist ...n as well as pre-term labor may increase the incid...hology, cognitive problems and poor school perform...ublished in the December 2009 issue of the Americ... adrenergic agonist drugs as a class are widely us...
Breaking Biology News(10 mins):A cell's 'cap' of bundled fibers could yield clues to disease 2DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2Treatments for asthma and pre-term labor may increase risk of autism in developing fetus 2Healthplace America Names Robert A Yungk Chief Executive Officer 51123 1Healthplace America Names Robert A Yungk Chief Executive Officer 51123 2Healthplace America Names Robert A Yungk Chief Executive Officer 51123 3Compirion Healthcare Sponsors Webinar Series 51121 1Compirion Healthcare Sponsors Webinar Series 51121 2New Tools Help Parents Reinforce Anti Smoking Message 51119 1New Tools Help Parents Reinforce Anti Smoking Message 51119 2(Date:12/2/2009)...c. 2 Reportlinker.com announces th...s catalogue: ,, Carbondioxide Incubators - A G...linker.com/p0164368/Carbondioxide-Incubators---A-G...re the most critical equipment used in microbiolog...ons for providing a controlled environment to grow...
(Date:12/2/2009).... 2 /PRNewswire-FirstCall/ - Oncolytics Biotech In...Q: ONCY ) announced today that in connection with ...riters have exercised in full their over-allotment... Each unit is comprised of one common share and 0.... at a price of US$3.00 per unit. Each whole common...
(Date:12/2/2009)...c. 2 S*BIO Pte Ltd today announced...or, SB1518, at The American Society of Hematology ... ,, Data will be presented on the clinical resu...18 detailing its safety, tolerability and pharmaco...vels ranging from 100 to 600 mg. These doses were ...
(Date:12/2/2009)...cientist, a leading scientific magazine covering t...e “Intelligent” EMCCD camera fourth am...ons of 2009. , (PRWEB) De... from Photometrics ®, a designer and manufac...r the life sciences, was ranked fourth among The S...
Breaking Biology Technology:Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3